Roger H Kobayashi Sudhir Gupta Isaac Melamed J Fernando Mandujano Ai Lan Kobayashi Bruce Ritchie Bob Geng Thomas Prescott Atkinson Syed Rehman Eva Turpel-Kantor Jiří Litzman
10.3389/fimmu.2019.00040
Front Immunol
2019 Feb 4;10:40.
scig antibodies immunoglobulins infections infusion site reactions primary immunodeficiencies
CC BY
https://pubmed.ncbi.nlm.nih.gov/30778345/
Immunization, Passive / methods Immunologic Deficiency Syndromes / drug therapy
Immunization, Passive / methods Immunologic Deficiency Syndromes / drug therapy Case Reports Research Support, Non-U.S. Gov't Adolescent Adult Aged Child Child, Preschool Female Humans Immunoglobulin G / administration & dosage Immunoglobulin G / blood Immunoglobulins, Intravenous / administration & dosage Immunoglobulins, Intravenous / pharmacokinetics Immunoglobulins, Intravenous / therapeutic use Infusions, Subcutaneous Male Middle Aged Young Adult Immunoglobulin G Immunoglobulins, Intravenous Octagam
PMC6369354
30778345
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
2019